Cited by 62Genetics and Neurodevelopmental DisordersEpilepsy research and treatmentCellular transport and secretion

The epilepsy-associated protein TBC1D24 is required for normal development, survival and vesicle trafficking in mammalian neurons

Open access
Finelli, Mattéa J, Aprile, Davide, Castroflorio, Enrico, Jeans, Alexander, Moschetta, Matteo, Chessum, Lauren, Degiacomi, Matteo T, Grasegger, Julia +8 more·2019·Human Molecular Genetics

Abstract

Mutations in the Tre2/Bub2/Cdc16 (TBC)1 domain family member 24 (TBC1D24) gene are associated with a range of inherited neurological disorders, from drug-refractory lethal epileptic encephalopathy and DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, seizures) to non-syndromic hearing loss. TBC1D24 has been implicated in neuronal transmission and maturation, although the molecular function of the gene and the cause of the apparently complex disease spectrum remain unclear. Importantly, heterozygous TBC1D24 mutation carriers have also been reported with seizures, suggesting that haploinsufficiency for TBC1D24 is significant clinically. Here we have systematically investigated an allelic series of disease-associated mutations in neurons alongside a new mouse model to investigate the consequences of TBC1D24 haploinsufficiency to mammalian neurodevelopment and synaptic physiology. The cellular studies reveal that disease-causing mutations that disrupt either of the conserved protein domains in TBC1D24 are implicated in neuronal development and survival and are likely acting as loss-of-function alleles. We then further investigated TBC1D24 haploinsufficiency in vivo and demonstrate that TBC1D24 is also crucial for normal presynaptic function: genetic disruption of Tbc1d24 expression in the mouse leads to an impairment of endocytosis and an enlarged endosomal compartment in neurons with a decrease in spontaneous neurotransmission. These data reveal the essential role for TBC1D24 at the mammalian synapse and help to define common synaptic mechanisms that could underlie the varied effects of TBC1D24 mutations in neurological disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddy370

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Autosomal recessive LOF variants in TBC1D24 lead to DEEs with myoclonic seizures and EIMFS, with dystonia.

    “Autosomal recessive LOF variants in TBC1D24, encoding a GTPase-activating protein essential for synaptic vesicle trafficking 105 , lead to DEEs with myoclonic seizures and EIMFS, with dystonia 106 .”

    From Developmental and epileptic encephalopathies (2024) · cites this paper as [105]

    The Introduction and Results (page numbers unavailable) link predominantly recessive TBC1D24 mutations and likely loss-of-function alleles to myoclonic epilepsy and early-onset epileptic encephalopathy. The paper does not identify EIMFS or dystonia as associated phenotypes, so those specifics are not supported. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Finelli, M. J., Aprile, D., Castroflorio, E., Jeans, A., Moschetta, M., Chessum, L., Degiacomi, M. T., Grasegger, J., Lupien-Meilleur, A., Bassett, A., Rossignol, E., Campeau, P. M., Bowl, M. R., Benfenati, F., Fassio, A., & Oliver, P. L.
Affiliations
  • University of Oxford (GB)
  • University of Genoa (IT)
  • Italian Institute of Technology (IT)
  • Mary Lyon Centre at MRC Harwell (GB)
  • Durham University (GB)
  • CHU Ste-Justine, Departments of Neurosciences and Pediatrics, Université de Montréal, Montreal, QC, Canada
  • Wellcome Sanger Institute (GB)
  • Centre Hospitalier Universitaire Sainte-Justine (CA)
  • Ospedale Policlinico San Martino (IT)
Corresponding author
  • Fassio, Anna
  • Oliver, Peter L
Venue
Human Molecular Genetics
Published
2018-10-17
Volume
28
Issue
4
Pages
584-597
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2896326568
Cited by
62
References
47
Citations by year
2026: 4 · 2025: 6 · 2024: 14 · 2023: 3 · 2022: 8 · 2021: 7 · 2020: 11 · 2019: 6 · 2018: 2
FWCI
3.99
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by)
  • Durham Research Online (Durham University) (acceptedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
  • Durham Research Online (Durham University) (submittedVersion, cc-by)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion, other-oa)
Funders
  • European Research Council Consolidator Award ‘PAROSIN’ (311394)
  • Medical Research Council Programme Grant (MR/P502005/1)
  • University of Genoa
  • Compagnia di San Paolo (2015.0546)
  • EU FP7 Integrating Project ‘Desire’ (602531)
  • Fondazione CARIGE
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
TBC1D24, haploinsufficiency, epilepsy, brain development, neuronal survival, vesicle trafficking, endocytosis, endosomes, presynaptic function, spontaneous neurotransmission, loss-of-function mutations, mouse model, synapses
MeSH terms
Amino Acid Sequence, Animals, Carrier Proteins, Disease Models, Animal, Endocytosis, Epilepsy, Gene Expression Regulation, Hand Deformities, Congenital, Hearing Loss, Sensorineural, Humans, Membrane Proteins, Intellectual Disability, Mutation, Nails, Malformed, Nerve Tissue Proteins, Neuronal Plasticity, Neurons, Pedigree, Seizures, Craniofacial Abnormalities, GTPase-Activating Proteins, Mice, Haploinsufficiency, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review